abstract |
The present invention relates to 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivative of the general formula (I) or a pharmaceutically acceptable salt thereof:n n n n n n n n [Wherein the substituents are as defined in the specification]n n n The compounds of the present invention are potent FSH receptor activators and can be used, for example, in ovarian laryngeal induction and IVF procedures to treat fertility disorders. |